Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants.

The research explores the impact of different forms of carprofen, a nonsteroidal anti-inflammatory drug (NSAID), on the metabolism of horse chondrocytes, cells within cartilage. The study showed carprofen could benefit by increasing proteoglycan synthesis, decreasing the production of PGE2, a biomarker of inflammation, and potentially promoting positive changes within the articular cartilage matrix of horses with osteoarthritis.

Research Methodology

• The study used cartilage derived from clinically normal horses and examined the effects of various forms of carprofen (individual R and S enantiomers and a racemic mixture) on proteoglycan neosynthesis, glycosaminoglycan (GAG) release and prostaglandin (PG) E2 production.
• These effects were tested on both unstimulated chondrocyte monolayers and cartilage explants, as well as on the same mediums exposed to carprofen and a recombinant human interleukin 1beta (IL-1), a protein that plays a key role in the regulation of immune and inflammatory responses.
• After treatment with carprofen, alone or combined with IL-1 for 48-96 hours, the medium was collected and the cartilage was digested.
• Proteoglycan synthesis was then gauged based on the amount of 35S-labeled proteoglycan found in the collected medium and the digested cartilage.
• The study also measured the total GAG content and used this data along with the 35S-proteoglycan levels to calculate the rate of proteoglycan degradation.
• Finally, a Radioimmunoassay was employed to measure PGE2 production.

Research Findings

• Carprofen was found to significantly lower PGE2 production in chondrocytes, both in its naturally occurring, unstimulated state, and when induced by IL-1.
• It also notably increased the synthesis of proteoglycan, a major component of cartilage, in unstimulated chondrocyte monolayers and cartilage explants.
• The release of GAG by the explants decreased simultaneously with the increase in proteoglycan synthesis.
• While IL-1 greatly reduced proteoglycan synthesis, the highest doses of carprofen were able to partially reverse this effect in the chondrocyte monolayers.

Research Conclusions

• The results suggest that carprofen could potentially have a beneficial effect on the proteoglycan metabolism of equine chondrocytes. This effect is particularly pronounced at high concentrations where it can overcome the inhibitory effects of IL-1 on proteoglycan synthesis.
• Carprofen was found to inhibit PGE2 production by both unstimulated and IL-1-stimulated chondrocytes. This indicates that it could play a role in reducing inflammation, a key factor contributing to many diseases, including osteoarthritis.
• The study concludes by proposing that carprofen could potentially induce beneficial changes in the articular cartilage matrix of horses with osteoarthritis.